Why the Janssen/Johnson & Johnson Pause Should Make You Feel Safer


Thomas G. McGinn, MD, MPH System Executive Vice President, CommonSpirit Health

On Tuesday, April 13, the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) jointly announced a recommendation to pause administration of the Janssen/Johnson & Johnson (J&J) vaccine as it undergoes further investigation for rare blood clotting events.

Publish Date: 

Tuesday, May 25, 2021

News

CommonSpirit Health Announces FY2022 Q1 Results

NOV 16, 2021

CHICAGO – Nov. 16, 2021 -- CommonSpirit Health released financial results today for its fiscal year 2022 first quarter.

Read More Additional information about CommonSpirit Health Announces FY2022 Q1 Results

Lloyd Dean: The stakes for health system CEOs are higher

NOV 04, 2021

In this interview with Becker's, CEO Lloyd Dean reflects on how his leadership style has evolved, how health care is changing, and his upcoming retirement.

Read More Additional information about Lloyd Dean: The stakes for health system CEOs are higher

CommonSpirit implements vaccine requirement with 97% compliance rate

NOV 04, 2021

Nearly 97% of our employees are now vaccinated or have received an approved medical or religious exemption. We are deeply grateful to all of our employees who have chosen to get vaccinated.

Read More Additional information about CommonSpirit implements vaccine requirement with 97% compliance rate